MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Longitudinal predictors of functional dependence in a multicentric Parkinson’s Disease cohort

    S. Becker, B. Callahan (Calgary, Canada)

    Objective: To explore clinical and cognitive predictors of functional dependence in a cohort of early Parkinson’s Disease (PD) patients. Background: Parkinson’s Disease (PD) patients are…
  • 2022 International Congress

    Mania induced by STN-DBS is related to the stimulation of the ventromedial subthalamic nucleus in Parkinson’s disease: a prospective study

    SP. Prange, ZL. Lin, MN. Nourredine, TD. Danaila, CL. Laurencin, OLB. Lagha-Boukbiza, MA. Anheim, HK. Klinger, NL. Longato, CP. Phillipps, JV. Voirin, GP. Polo, ES. Simon, PM. Mertens, ASR. Rolland, DD. Devos, EM. Metereau, CT. Tranchant, ST. Thobois (Bron, France)

    Objective: To investigate the incidence, risk and etiological factors, clinical management and consequences of mania following subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease…
  • 2022 International Congress

    Determinants of symptom severity in Parkinson’s disease: the International Vacation Survey

    J. Janssen Daalen, J. Hubbers, M. Sharifi Bonab, S. Mathur, D. Thijssen, B. Bloem, M. Meinders (Nijmegen, Netherlands)

    Objective: As insight in the drivers of varying symptom severity might help manage symptoms, this study investigates the association between symptom severity and contextual factors…
  • 2022 International Congress

    Comparison of efficacy and safety of adjunct treatments to levodopa in patients with Parkinson’s disease and wearing-off: A network meta-analysis of randomized, double-blind trials

    Y. Kogo, W. Sako, M. Koebisu, H. Yamakage, T. Ishida, N. Hattori (Tokyo, Japan)

    Objective: To determine the rankings for efficacy and tolerability of levodopa adjuncts in patients with Parkinson’s disease (PD) and wearing-off by network meta-analysis. Background: When…
  • 2022 International Congress

    Structural MRI prediction of freezing of gait in Parkinson’s disease after deep brain stimulation

    T. Ollivier, R. Viard, A. Rolland, R. Lopes, L. Defebvre, G. Kuchcinski, D. Devos, C. Moreau (Lille, France)

    Objective: 1) To describe the evolution of FOG in a large cohort of patients at 1 year postoperatively from bilateral STN-DBS in PD. 2) To…
  • 2022 International Congress

    The effect of split-belt-treadmill training on freezing related gait deficits in people with Parkinson’s disease

    C. Schlenstedt, J. Seuthe, F. Hulzinga, N. D'Cruz, P. Ginis, A. Nieuwboer (Hamburg, Germany)

    Objective: To compare Split-Belt treadmill (SBT) training with regular treadmill (tied-belt treadmill, TBT) training to improve freezing related gait deficits and to investigate whether effects…
  • 2022 International Congress

    Identification and functional characterization of genetic modifier of penetrance in G2019S LRRK2-associated Parkinson’s disease through family whole genome sequencing

    J. Ohnmacht, D. Bobbili, P. May, E. Glaab, J. Kaye, S. Finkbeiner, R. Krüger (Strassen, Luxembourg)

    Objective: Trait- or disease-associated genetic variants contribute to substantial variability and penetrance of complex traits and diseases in humans. Several causative genes and risk factors…
  • 2022 International Congress

    Speech disorders and axial motor impairment in advanced Parkinson’s Disease: two sides of the same coin?

    G. Di Rauso, C. Budriesi, F. Cavallieri, A. Gessani, S. Coniglio, V. Rispoli, F. Valzania, F. Antonelli (Modena, Italy)

    Objective: To examine possible correlations between axial motor features, disease severity and speech parameters in advanced Parkinson’s Disease (PD) patients and to evaluate chronic dopaminergic…
  • 2022 International Congress

    Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital

    DA. Soraya, D. Tunjungsari, A. Tiksnadi (Jakarta, Indonesia)

    Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…
  • 2022 International Congress

    Long-read nanopore sequencing for cost-effective and comprehensive analysis of GBA mutations in Norwegian patients with Parkinson’s disease

    C. Gabbert, S. Schaake, T. Lüth, C. Klein, J. Aasly, M. Farrer, J. Trinh (Lübeck, Germany)

    Objective: To use nanopore sequencing as a cost-effective strategy to determine the association and prevalence of mutations within the GBA gene in patients with Parkinson’s disease (PD) from the Norwegian population.…
  • « Previous Page
  • 1
  • …
  • 221
  • 222
  • 223
  • 224
  • 225
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley